Fibronostics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.5M

  • Investors
  • 6

Fibronostics General Information

Description

Developer of a non-invasive diagnostic testing system designed to provide algorithm-based health monitoring services. The company's system focuses on assessing the existence or progression of chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea, enabling doctors to detect any early signs in order to facilitate efficient monitoring of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 615 Baronne Street
  • Suite 100
  • New Orleans, LA
  • United States
+1 (888)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 615 Baronne Street
  • Suite 100
  • New Orleans, LA
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fibronostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 15-Jun-2022 $6.5M Completed Generating Revenue
3. Later Stage VC (Series A) 24-Aug-2020 Completed Generating Revenue
2. Early Stage VC 31-May-2019 Completed Generating Revenue
1. Early Stage VC 01-Jan-2018 Completed Generating Revenue
To view Fibronostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fibronostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a non-invasive diagnostic testing system designed to provide algorithm-based health monitoring services. Th
Decision/Risk Analysis
New Orleans, LA
27 As of 2026

Pune, India
 

Singapore, Singapore
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fibronostics Competitors (13)

One of Fibronostics’s 13 competitors is In-Med Prognostics, a Venture Capital-Backed company based in Pune, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
In-Med Prognostics Venture Capital-Backed Pune, India
HistoIndex Venture Capital-Backed Singapore, Singapore
Biofourmis Formerly VC-backed Boston, MA
Click Therapeutics Venture Capital-Backed New York, NY
Sleepiz Venture Capital-Backed Zurich, Switzerland
You’re viewing 5 of 13 competitors. Get the full list »

Fibronostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fibronostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AT Capital Group Family Office Minority
Elev8.vc Venture Capital Minority
Ayala Healthcare Holdings PE-Backed Company Minority
Vigos Corporation Minority
SPRIM Global Investments Holding Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Fibronostics Acquisitions (1)

Fibronostics’s most recent deal was a Merger/Acquisition with Stone Clinical Laboratories. The deal was made on 27-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Stone Clinical Laboratories 27-Oct-2025 Merger/Acquisition Laboratory Services (Healthcare)
To view Fibronostics’s complete acquisitions history, request access »

Fibronostics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Stone Clinical Laboratories Santa Rosa Beach, FL 2015

Fibronostics FAQs

  • When was Fibronostics founded?

    Fibronostics was founded in 2015.

  • Where is Fibronostics headquartered?

    Fibronostics is headquartered in New Orleans, LA.

  • What is the size of Fibronostics?

    Fibronostics has 27 total employees.

  • What industry is Fibronostics in?

    Fibronostics’s primary industry is Decision/Risk Analysis.

  • Is Fibronostics a private or public company?

    Fibronostics is a Private company.

  • What is Fibronostics’s current revenue?

    The current revenue for Fibronostics is .

  • How much funding has Fibronostics raised over time?

    Fibronostics has raised $14.8M.

  • Who are Fibronostics’s investors?

    AT Capital Group, Elev8.vc, Ayala Healthcare Holdings, Vigos, and SPRIM Global Investments are 5 of 6 investors who have invested in Fibronostics.

  • Who are Fibronostics’s competitors?

    In-Med Prognostics, HistoIndex, Biofourmis, Click Therapeutics, and Sleepiz are some of the 13 competitors of Fibronostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process